Search:
Home [Spacer] CellSearch [Spacer] GeneSearch [Spacer] Resources [Spacer] News & Events [Spacer] Contact Us
Delivering the Promise of Personalized Medicine
Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians and patients with high-value in vitro diagnostic oncology products. Veridex's products will significantly benefit patients through earlier disease detection, and will enable personalized strategies to improve patient management and outcomes.

News & Events

CellSearch™ Now Indicated For Metastatic Prostate Cancer

Time Magazine Names GeneSearch™ One Of The Top 10 Medical Breakthroughs In 2007

FDA Approves First Gene-Based Test To Detect The Spread Of Breast Cancer Into Lymph Nodes
GeneSearch CellSearch

For Newly Diagnosed Breast Cancer Patients:

The GeneSearch™ Breast Lymph Node (BLN) Assay is the first FDA- approved molecular diagnostics assay for breast lymph node testing.
More Info


For Metastatic Breast, Colorectal, or Prostate Cancer Patients

The CellSearch™ System is the first diagnostic test to automate the detection and enumeration of circulating tumor cells (CTCs) and is the standard in a new class of diagnostic tools.
More Info

For Patients For Patients